1-3 of 3
Hanneke ter Burg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Linking Microenvironmental Signals to Metabolic Switches and Drug Responses in Chronic Lymphocytic Leukemia

Zhenghao Chen, Gaspard Cretenet, Hanneke ter Burg, Gabriela Andrejeva, Jeffrey C Rathmell, Francesco Forconi, MD DM, PhD FRCPath, Gerritje J. W. van der Windt, Arnon P. Kater, Eric Eldering
Journal: Blood
Blood (2019) 134 (Supplement_1): 479.
https://doi.org/10.1182/blood-2019-123005
Published: 2019
Journal Articles

Dissecting the Role of Individual Bcl-2 Members in Response and Resistance to Ibrutinib or Venetoclax in CLL

Fabio Brocco, Hanneke ter Burg, Stacey Fernandes, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Francesco Forconi, MD DM, PhD FRCPath, Rachel M Guerra, Gregory Bird, Loren D Walensky, Jennifer R. Brown, MD PhD, Arnon P Kater, Eric Eldering
Journal: Blood
Blood (2017) 130 (Supplement 1): 262.
https://doi.org/10.1182/blood.V130.Suppl_1.262.262
Published: 2017
Journal Articles

Bcl-2 Members As Drug Target and Biomarkers for Response to Ibrutinib and Venetoclax in CLL

Eric Eldering, PhD, Victor Peperzak, PhD, Hanneke ter Burg, Stacey M. Fernandes, MS, Jennifer R. Brown, MD PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2043.
https://doi.org/10.1182/blood.V128.22.2043.2043
Published: 2016